Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.

Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.

Item
http://www.wikidata.org/entity/Q30458371
Update on Inflammatory Biomarkers and Treatments in Ischemic StrokeRisk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple SclerosisPatient experience and practice trends in multiple sclerosis - clinical utility of fingolimod.Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin FRetinal hemorrhages following fingolimod treatment for multiple sclerosis; a case report.Effect of Fingolimod on Platelet Count Among Multiple Sclerosis Patients.Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathwaysPhase II anti-inflammatory and immune-modulating drugs for acute ischaemic stroke.Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature.Sphingomimetic multiple sclerosis drug FTY720 activates vesicular synaptobrevin and augments neuroendocrine secretion.The effect of S1P receptor signaling pathway on the survival and drug resistance in multiple myeloma cells.Considerations on long-term immuno-intervention in the treatment of multiple sclerosis: an expert opinion.Safety concerns and risk management of multiple sclerosis therapies.Multiple sclerosis treatment with fingolimod: profile of non-cardiologic adverse events.Cardiac Safety of Ozanimod, a Novel Sphingosine-1-Phosphate Receptor Modulator: Results of a Thorough QT/QTc Study.Persistent headache in patients with multiple sclerosis starting treatment with fingolimod.
P2860

Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.

Item
http://www.wikidata.org/entity/Q30458371
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.
@ast
Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.
@en
type
label
Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.
@ast
Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.
@en
prefLabel
Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.
@ast
Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.
@en
P2093
P2860
P304
P31
P356
10.1517/14740338.2014.920820
P407
P433
P478
P577
P698
P921